Skip to content

Piezo-type mechanosensitive ion channel component 2 (PIEZO2)

Homo sapiens — UniProt Q9H5I5

Gene: PIEZO2Homo sapiensSwissProt reviewedIon channel

Data last refreshed: (UniProt release unknown)

Key facts

Piezo-type mechanosensitive ion channel component 2 (PIEZO2) is a protein from Homo sapiens identified by UniProt accession Q9H5I5, 2752 residues long. MolForge cross-references it against 0 known binders and 203 disease associations.

  • UniProt accession: Q9H5I5; gene symbol PIEZO2.
  • Organism: Homo sapiens.
  • Length: 2752 amino acids.
  • Target class: Ion channel.
  • Top disease associations (Open Targets): Arthrogryposis with oculomotor limitation and electroretinal anomalies, arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome and Gordon syndrome.
  • 3D structure: AlphaFold model available.

Target properties

Protein namePiezo-type mechanosensitive ion channel component 2
UniProt accessionQ9H5I5
GenePIEZO2
OrganismHomo sapiens
Length2752 residues
Molecular weight—
EC numbers—
Target classIon channel (inferred from UniProt keywords / EC)
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (203)

Diseases linked to this target (Open Targets).

  • Arthrogryposis with oculomotor limitation and electroretinal anomalies · score 0.79
  • arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome · score 0.75
  • Gordon syndrome · score 0.74
  • distal arthrogryposis · score 0.66
  • Marden-Walker syndrome · score 0.64
  • genetic disorder · score 0.53
  • fetal akinesia deformation sequence · score 0.45
  • arthrogryposis multiplex congenita · score 0.45
  • fetal akinesia deformation sequence 1 · score 0.45
  • diastolic blood pressure · score 0.44

3D Structure (8)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q9H5I5-F2alphafoldPREDICTED77.47—
AF-Q9H5I5-F1alphafoldPREDICTED77.29—
AF-Q9H5I5-F3alphafoldPREDICTED74.03—
AF-Q9H5I5-F6alphafoldPREDICTED73.84—
AF-Q9H5I5-F4alphafoldPREDICTED73.55—
AF-Q9H5I5-F7alphafoldPREDICTED72.83—
AF-Q9H5I5-F8alphafoldPREDICTED71.62—
AF-Q9H5I5-F5alphafoldPREDICTED71.55—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q9H5I5.

Amino-acid sequence (2752 residues)

MASEVVCGLI FRLLLPICLA VACAFRYNGL SFVYLIYLLL IPLFSEPTKT TMQGHTGRLL KSLCFISLSF LLLHIIFHIT LVSLEAQHRI APGYNCSTWE KTFRQIGFES LKGADAGNGI RVFVPDIGMF IASLTIWLLC RNIVQKPVTD EAAQSNPEFE NEELAEGEKI DSEEALIYEE DFNGGDGVEG ELEESTKLKM FRRLASVASK LKEFIGNMIT TAGKVVVTIL LGSSGMMLPS LTSSVYFFVF LGLCTWWSWC RTFDPLLFSC LCVLLAIFTA GHLIGLYLYQ FQFFQEAVPP NDYYARLFGI KSVIQTDCSS TWKIIVNPDL SWYHHANPIL LLVMYYTLAT LIRIWLQEPL VQDEGTKEED KALACSPIQI TAGRRRSLWY ATHYPTDERK LLSMTQDDYK PSDGLLVTVN GNPVDYHTIH PSLPMENGPG KADLYSTPQY RWEPSDESSE KREEEEEEKE EFEEERSREE KRSIKVHAMV SVFQFIMKQS YICALIAMMA WSITYHSWLT FVLLIWSCTL WMIRNRRKYA MISSPFMVVY GNLLLILQYI WSFELPEIKK VPGFLEKKEP GELASKILFT ITFWLLLRQH LTEQKALQEK EALLSEVKIG SQENEEKDEE LQDIQVEGEP KEEEEEEAKE EKQERKKVEQ EEAEEEDEQD IMKVLGNLVV AMFIKYWIYV CGGMFFFVSF EGKIVMYKII YMVLFLFCVA LYQVHYEWWR KILKYFWMSV VIYTMLVLIF IYTYQFENFP GLWQNMTGLK KEKLEDLGLK QFTVAELFTR IFIPTSFLLV CILHLHYFHD RFLELTDLKS IPSKEDNTIY RLAHPEGSLP DLTMMHLTAS LEKPEVRKLA EPGEEKLEGY SEKAQKGDLG KDSEESEEDG EEEEESEEEE ETSDLRNKWH LVIDRLTVLF LKFLEYFHKL QVFMWWILEL HIIKIVSSYI IWVSVKEVSL FNYVFLISWA FALPYAKLRR LASSVCTVWT CVIIVCKMLY QLQTIKPENF SVNCSLPNEN QTNIPFNELN KSLLYSAPID PTEWVGLRKS SPLLVYLRNN LLMLAILAFE VTIYRHQEYY RGRNNLTAPV SRTIFHDITR LHLDDGLINC AKYFINYFFY KFGLETCFLM SVNVIGQRMD FYAMIHACWL IAVLYRRRRK AIAEIWPKYC CFLACIITFQ YFICIGIPPA PCRDYPWRFK GASFNDNIIK WLYFPDFIVR PNPVFLVYDF MLLLCASLQR QIFEDENKAA VRIMAGDNVE ICMNLDAASF SQHNPVPDFI HCRSYLDMSK VIIFSYLFWF VLTIIFITGT TRISIFCMGY LVACFYFLLF GGDLLLKPIK SILRYWDWLI AYNVFVITMK NILSIGACGY IGTLVHNSCW LIQAFSLACT VKGYQMPAAN SPCTLPSGEA GIIWDSICFA FLLLQRRVFM SYYFLHVVAD IKASQILASR GAELFQATIV KAVKARIEEE KKSMDQLKRQ MDRIKARQQK YKKGKERMLS LTQEPGEGQD MQKLSEEDDE READKQKAKG KKKQWWRPWV DHASMVRSGD YYLFETDSEE EEEEELKKED EEPPRRSAFQ FVYQAWITDP KTALRQRHKE KKRSAREERK RRRKGSKEGP VEWEDREDEP IKKKSDGPDN IIKRIFNILK FTWVLFLATV DSFTTWLNSI SREHIDISTV LRIERCMLTR EIKKGNVPTR ESIHMYYQNH IMNLSRESGL DTIDEHPGAA SGAQTAHRMD SLDSHDSISS EPTQCTMLYS RQGTTETIEE VEAEQEEEAG STAPEPREAK EYEATGYDVG AMGAEEASLT PEEELTQFST LDGDVEAPPS YSKAVSFEHL SFGSQDDSAG KNRMAVSPDD SRTDKLGSSI LPPLTHELTA SELLLKKMFH DDELEESEKF YVGQPRFLLL FYAMYNTLVA RSEMVCYFVI ILNHMVSASM ITLLLPILIF LWAMLSVPRP SRRFWMMAIV YTEVAIVVKY FFQFGFFPWN KNVEVNKDKP YHPPNIIGVE KKEGYVLYDL IQLLALFFHR SILKCHGLWD EDDMTESGMA REESDDELSL GHGRRDSSDS LKSINLAASV ESVHVTFPEQ QTAVRRKRSG SSSEPSQRSS FSSNRSQRGS TSTRNSSQKG SSVLSIKQKG KRELYMEKLQ EHLIKAKAFT IKKTLEIYVP IKQFFYNLIH PEYSAVTDVY VLMFLADTVD FIIIVFGFWA FGKHSAAADI TSSLSEDQVP GPFLVMVLIQ FGTMVVDRAL YLRKTVLGKV IFQVILVFGI HFWMFFILPG VTERKFSQNL VAQLWYFVKC VYFGLSAYQI RCGYPTRVLG NFLTKSYNYV NLFLFQGFRL VPFLTELRAV MDWVWTDTTL SLSSWICVED IYAHIFILKC WRESEKRYPQ PRGQKKKKVV KYGMGGMIIV LLICIVWFPL LFMSLIKSVA GVINQPLDVS VTITLGGYQP IFTMSAQQSQ LKVMDQQSFN KFIQAFSRDT GAMQFLENYE KEDITVAELE GNSNSLWTIS PPSKQKMIHE LLDPNSSFSV VFSWSIQRNL SLGAKSEIAT DKLSFPLKNI TRKNIAKMIA GNSTESSKTP VTIEKIYPYY VKAPSDSNSK PIKQLLSENN FMDITIILSR DNTTKYNSEW WVLNLTGNRI YNPNSQALEL VVFNDKVSPP SLGFLAGYGI MGLYASVVLV IGKFVREFFS GISHSIMFEE LPNVDRILKL CTDIFLVRET GELELEEDLY AKLIFLYRSP ETMIKWTREK TN

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with PIEZO2?

The strongest Open Targets associations for PIEZO2 are Arthrogryposis with oculomotor limitation and electroretinal anomalies, arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome, Gordon syndrome, distal arthrogryposis and Marden-Walker syndrome.

How long is the PIEZO2 protein?

The Homo sapiens PIEZO2 protein (UniProt Q9H5I5) is 2752 amino acids long.

Browse: Targets: P · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Piezo-type mechanosensitive ion channel component 2 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ9H5I5
GenePIEZO2
OrganismHomo sapiens
Length2752
Binders0
Diseases203
View on UniProt